Compare CDMOs with FDA registration for US-market pharmaceutical manufacturing. Filter by product type, inspection history, and manufacturing capabilities.
729 companies listed
FDA registration means a manufacturing facility has registered with the US Food and Drug Administration as required by the Federal Food, Drug, and Cosmetic Act. Every domestic and foreign establishment that manufactures, repacks, or relabels drugs for the US market must register annually. Registration is a legal requirement, not an endorsement of quality.
Registered does not mean approved. FDA registration is a notification, not a certification. The FDA does not "approve" manufacturing facilities -- it approves specific drug products. However, registered facilities are subject to FDA inspection, and inspection history is public record. Look up any facility's inspection results, Form 483 observations, and warning letters on the FDA's website.
What matters more than registration itself is inspection outcome. A facility with a clean inspection history (no Form 483 observations, or observations that were promptly remediated) demonstrates stronger quality systems than one with repeated citations. Voluntary Action Indicated (VAI) outcomes are common and acceptable. Official Action Indicated (OAI) outcomes suggest systemic quality problems.
United States
BioSpectra Inc. is a privately-owned manufacturer of premium pharmaceutical ingredients and bulk cGMP fine chemicals based in Bangor, Pennsylvania. The company produces cGMP biological buffers, process fine chemicals, functional excipients, and new chemical entities (NCEs) to IPEC and ICH Q7 standards. While it has launched contract manufacturing services from an FDA-registered facility, its core business is raw material and excipient supply to biopharma companies.
China
BLi-T (Hefei) Chemical Co., Ltd. is a Chinese chemical supplier offering a wide range of products including cosmetic raw materials, fine chemicals, water treatment chemicals, vitamins, food additives, solvents, pharmaceutical chemicals, and agricultural chemicals. The company provides customized production and has advanced manufacturing processes including nitration, sulfonation, halogenation, hydrogenation, fermentation, and enzyme catalysis. BLi-T is a raw material and chemical supplier, not a pharmaceutical CDMO.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
Norway
Borregaard is a Norwegian biorefinery company that produces specialty cellulose and vanillin-based products. Its pharmaceutical intermediates division supplies excipients and cellulose-derived raw materials to the pharmaceutical industry. The company is FDA-registered for API manufacture but operates as a raw material and intermediate supplier, not as a CDMO.